.After looking at phase 1 record, Nuvation Bio has determined to stop work on its one-time top BD2-s...
.Zevra Rehabs' unusual condition medication appears to be on the road to authorization this loss aft...
.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy failing has actually blown a $230 tho...
.After more than twenty years of service neurodegenerative diseases, Swiss biotech hvac Invulnerable...
.GSK has actually junked a phase 2 individual papillomavirus (HPV) vaccination from its pipeline aft...
.OS Therapies are going to specify on the NYSE American sell swap this morning through a $6.4 millio...
.ALX Oncology's period 2 gastric cancer action cost has diminished. After observing its CD47 blocker...
.Another of Ionis Pharmaceuticals' vital midphase readouts has fallen short of expectations, motivat...
.While Biogen's pharma peers are looking for late-stage assets along with little risk, chief executi...
.Instil Bio has been a biotech in search of a pipe after it scrapped its own lead assets over the fi...